United States Biotechnology & Medical Research

Raphael Pharmaceutical Inc (RAPH)

Track

Stock chart
Ticker: RAPH Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Ofir Guy
President
1 purchase — total 150,000 USD
Buy 22 Sep 2009
Value US$3,198,205.71 | Price 137.52 | Shares 66,413
Buy 3 Sep 2009
Value US$3,577,115.98 | Price 165.22 | Shares 67,667
Buy 2 Dec 2008
Value US$6,500.00 | Price 0.07 | Shares 100,000
Buy 2 Dec 2008
Value US$6,000.00 | Price 0.06 | Shares 100,000
Buy 24 Nov 2008
Value US$1,800.00 | Price 0.09 | Shares 20,000
Buy 24 Nov 2008
Value US$1,200.00 | Price 0.08 | Shares 15,000
Buy 24 Nov 2008
Value US$1,050.00 | Price 0.07 | Shares 15,000
Buy 24 Nov 2008
Value US$1,200.00 | Price 0.08 | Shares 15,000
Buy 12 Nov 2008
Value US$5,000.00 | Price 0.10 | Shares 50,000
Buy 4 Nov 2008
Value US$1,600.00 | Price 0.16 | Shares 10,000
Buy 4 Nov 2008
Value US$6,750.00 | Price 0.15 | Shares 45,000
Buy 30 Sep 2008
Value US$5,775.00 | Price 0.15 | Shares 38,500
Buy 30 Sep 2008
Value US$700.00 | Price 0.14 | Shares 5,000
Buy 29 Sep 2008
Value US$750.00 | Price 0.15 | Shares 5,000
Buy 26 Sep 2008
Value US$3,000.00 | Price 0.15 | Shares 20,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2009-09-22 2009-09-22 B Purchase Ofir Guy

President

Executive Director Large shareholder
66,413 -8.1%
137.52
US$3,198,206 		66,413 -8.1% 137.52 US$3,198,206
2009-09-22 2009-09-03 B Purchase Ofir Guy

President

Executive Director Large shareholder
67,667 -37.4%
165.22
US$3,577,116 		67,667 -37.4% 165.22 US$3,577,116
2008-12-04 2008-12-02 B Purchase Ofir Guy

President

Executive Director Large shareholder
21,915 -37.9%
476.29
US$3,182,082 		21,915 -37.9% 476.29 US$3,182,082
2008-12-04 2008-12-02 B Purchase Ofir Guy

President

Executive Director Large shareholder
100,000 +0.5%
0.06
US$6,000 		100,000 +0.5% 0.06 US$6,000
2008-11-25 2008-11-24 B Purchase Ofir Guy

President

Executive Director Large shareholder
20,000 +0.6%
0.09
US$1,800 		20,000 +0.6% 0.09 US$1,800
2008-11-25 2008-11-24 B Purchase Ofir Guy

President

Executive Director Large shareholder
15,000 +0.4%
0.08
US$1,200 		15,000 +0.4% 0.08 US$1,200
2008-11-25 2008-11-24 B Purchase Ofir Guy

President

Executive Director Large shareholder
15,000 +0.4%
0.07
US$1,050 		15,000 +0.4% 0.07 US$1,050
2008-11-25 2008-11-24 B Purchase Ofir Guy

President

Executive Director Large shareholder
15,000 +0.1%
0.08
US$1,200 		15,000 +0.1% 0.08 US$1,200
2008-11-25 2008-11-12 B Purchase Ofir Guy

President

Executive Director Large shareholder
50,000 +0.2%
0.10
US$5,000 		50,000 +0.2% 0.10 US$5,000
2008-11-25 2008-11-04 B Purchase Ofir Guy

President

Executive Director Large shareholder
10,000 +0.0%
0.16
US$1,600 		10,000 +0.0% 0.16 US$1,600
2008-11-25 2008-11-04 B Purchase Ofir Guy

President

Executive Director Large shareholder
45,000 +0.2%
0.15
US$6,750 		45,000 +0.2% 0.15 US$6,750
2008-10-03 2008-09-30 B Purchase Ofir Guy

President

Executive Director Large shareholder
38,500 +1.1%
0.15
US$5,775 		38,500 +1.1% 0.15 US$5,775
2008-10-03 2008-09-30 B Purchase Ofir Guy

President

Executive Director Large shareholder
5,000 +0.1%
0.14
US$700 		5,000 +0.1% 0.14 US$700
2008-09-29 2008-09-29 B Purchase Ofir Guy

President and Director

Executive Director Large shareholder
5,000 +25.0%
0.15
US$750 		5,000 +25.0% 0.15 US$750
2008-09-29 2008-09-26 B Purchase Ofir Guy

President and Director

Executive Director Large shareholder
20,000 +inf%
0.15
US$3,000 		20,000 +inf% 0.15 US$3,000
Explore more

More insider trading research around Raphael Pharmaceutical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America